the hanover insurance group inc. - THG
THG
Close Chg Chg %
247.89 0.30 0.12%
Closed Market
248.18
+0.30 (0.12%)
Volume: 156.20K
Last Updated:
Nov 13, 2026, 3:59 PM EDT
Company Overview: the hanover insurance group inc. - THG
THG Key Data
| Open $249.96 | Day Range 247.63 - 250.96 |
| 52 Week Range 166.66 - 256.74 | Market Cap $8.54B |
| Shares Outstanding 34.37M | Public Float 33.99M |
| Beta 0.25 | Rev. Per Employee N/A |
| P/E Ratio 11.88 | EPS $21.33 |
| Yield 153.23% | Dividend $0.95 |
| EX-DIVIDEND DATE Sep 11, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 296.52K |
THG Performance
| 1 Week | 2.21% | ||
| 1 Month | 6.56% | ||
| 3 Months | 10.20% | ||
| 1 Year | 36.93% | ||
| 5 Years | 95.33% |
THG Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
10
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 242.75 | |
| Number of Ratings | 10 | Current Quarters Estimate | 5.475 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 21.073 | |
| Last Quarter’s Earnings | 5.15 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 19.09 | Next Fiscal Year Estimate | 19.901 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 8 | 9 | 9 |
| Mean Estimate | 5.48 | 5.07 | 21.07 | 19.90 |
| High Estimates | 6.13 | 5.68 | 21.85 | 21.00 |
| Low Estimate | 5.17 | 4.63 | 20.37 | 19.00 |
| Coefficient of Variance | 5.31 | 6.12 | 2.05 | 3.55 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 8 | 8 | 6 |
| UNDERWEIGHT | 0 | 0 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for The Hanover Insurance Group Inc. - THG
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for The Hanover Insurance Group Inc. - THG
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 189,305 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $104.11 per share | 19,708,543.55 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 225,844 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $117.22 per share | 26,473,433.68 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 165,646 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $248.53 per share | 41,168,000.38 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 164,546 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $247.93 per share | 40,795,889.78 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 154,153 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $249.37 per share | 38,441,133.61 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | 151,224 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $250 per share | 37,806,000.00 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 13, 2026 | John Conner Roche President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 6, 2026 | Theodore H. Bunting Director | 5,388 | Bona fide gift | 0.00 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 6,004 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $249.69 per share | 1,499,138.76 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 8,314 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $248.98 per share | 2,070,019.72 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 15,950 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $139.51 per share | 2,225,184.50 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 12,884 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $115.35 per share | 1,486,169.40 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 9,305 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $118.54 per share | 1,103,014.70 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | 6,707 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $117.22 per share | 786,194.54 |
| Nov 6, 2026 | Willard T. Lee Executive Vice President | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 4, 2025 | Bryan J. Salvatore Executive Vice President | 25,678 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $185.91 per share | 4,773,796.98 |